J&J Files 8-K on Debt Issuances
Ticker: JNJ · Form: 8-K · Filed: 2025-02-20T00:00:00.000Z
Sentiment: neutral
Topics: debt-issuance, financing, notes
Related Tickers: JNJ
TL;DR
J&J dropped an 8-K on a bunch of new debt notes with varying maturities and rates.
AI Summary
On February 20, 2025, Johnson & Johnson filed an 8-K report detailing various debt issuances. These include notes due in November 2028, November 2032, 2035, November 2036, and November 2044, with coupon rates ranging from 1.150% to 3.550%. The filing also includes common stock information.
Why It Matters
This filing provides insight into Johnson & Johnson's capital structure and its ongoing financing activities, which can impact its cost of capital and financial flexibility.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of debt issuances and does not indicate any immediate financial distress or significant operational changes.
Key Numbers
- 1.150% — Notes Due November 2028 Coupon Rate (Represents a specific debt instrument issued by J&J.)
- 3.550% — Notes Due November 2044 Coupon Rate (Represents a specific debt instrument issued by J&J.)
Key Players & Entities
- Johnson & Johnson (company) — Registrant
- February 20, 2025 (date) — Report Date
- 1.150% (dollar_amount) — Coupon Rate for Notes Due November 2028
- 3.550% (dollar_amount) — Coupon Rate for Notes Due November 2044
FAQ
What are the specific maturity dates for the notes mentioned in the filing?
The filing mentions notes due in November 2028, November 2032, 2035, November 2036, and November 2044.
What is the lowest coupon rate mentioned for the new debt issuances?
The lowest coupon rate mentioned is 1.150% for notes due November 2028.
What is the highest coupon rate mentioned for the new debt issuances?
The highest coupon rate mentioned is 3.550% for notes due November 2044.
What is the filing date of this 8-K report?
The filing date of this 8-K report is February 20, 2025.
What type of financial instruments are primarily detailed in this 8-K filing?
The filing primarily details various issuances of notes (debt) with different coupon rates and maturity dates.
From the Filing
0001193125-25-030851.txt : 20250220 0001193125-25-030851.hdr.sgml : 20250220 20250220172635 ACCESSION NUMBER: 0001193125-25-030851 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 27 CONFORMED PERIOD OF REPORT: 20250220 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250220 DATE AS OF CHANGE: 20250220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 25647436 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 8-K 1 d866332d8k.htm 8-K 8-K One Johnson & Johnson Plaza false 0000200406 0000200406 2025-02-20 2025-02-20 0000200406 us-gaap:CommonStockMember 2025-02-20 2025-02-20 0000200406 jnj:A1.150NotesDueNovember2028Member 2025-02-20 2025-02-20 0000200406 jnj:A3.20NotesDueNovember2032Member 2025-02-20 2025-02-20 0000200406 jnj:A1.650NotesDue2035Member 2025-02-20 2025-02-20 0000200406 jnj:A3.350NotesDueNovember2036Member 2025-02-20 2025-02-20 0000200406 jnj:A3.550NotesDueNovember2044Member 2025-02-20 2025-02-20     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 20, 2025     Johnson & Johnson (Exact name of registrant as specified in its charter)       New Jersey   1-3215   22-1024240 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.) One Johnson & Johnson Plaza , New Brunswick , New Jersey 08933 (Address of Principal Executive Offices) Registrant’s telephone number, including area code: 732 - 524-0400     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, Par Value $1.00   JNJ   New York Stock Exchange 1.150% Notes Due November 2028   JNJ28   New York Stock Exchange 3.200% Notes Due June 2032   JNJ32   New York Stock Exchange 1.650% Notes Due May 2035   JNJ35   New York Stock Exchange 3.350% Notes Due June 2036   JNJ36A   New York Stock Exchange 3.550% Notes Due June 2044   JNJ44   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐